Brazil registered 978 new COVID-19 deaths, bringing the death toll to 231,012, the Ministry of Health said on Saturday.
Additionally, another 50,630 new COVID-19 cases were recorded, taking the nationwide tally to 9,497,795.
Sao Paulo, the most populous and the hardest-hit state in the country, has reported 1,845,086 cases and 54,545 deaths, followed by Rio de Janeiro, with 537,824 cases and 30,596 deaths.
Brazil began its national vaccination program in mid-January and has immunized more than 3.3 million people so far.
At the moment, the vaccines available in Brazil are those made by Chinese pharmaceutical company Sinovac and British-Swedish company AstraZeneca.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.